These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 15065018

  • 1. Interferon-gamma induces caspase-8 in neuroblastomas without affecting methylation of caspase-8 promoter.
    Kim S, Kang J, Evers BM, Chung DH.
    J Pediatr Surg; 2004 Apr; 39(4):509-15. PubMed ID: 15065018
    [Abstract] [Full Text] [Related]

  • 2. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.
    Yang X, Merchant MS, Romero ME, Tsokos M, Wexler LH, Kontny U, Mackall CL, Thiele CJ.
    Cancer Res; 2003 Mar 01; 63(5):1122-9. PubMed ID: 12615731
    [Abstract] [Full Text] [Related]

  • 3. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S, Kang J, Qiao J, Thomas RP, Evers BM, Chung DH.
    J Pediatr Surg; 2004 Apr 01; 39(4):516-21. PubMed ID: 15065019
    [Abstract] [Full Text] [Related]

  • 4. Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death.
    Tsushima H, Imaizumi Y, Imanishi D, Fuchigami K, Tomonaga M.
    Exp Hematol; 1999 Mar 01; 27(3):433-40. PubMed ID: 10089905
    [Abstract] [Full Text] [Related]

  • 5. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.
    Int J Oncol; 2004 Dec 01; 25(6):1849-57. PubMed ID: 15547726
    [Abstract] [Full Text] [Related]

  • 6. Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma.
    Yang X, Thiele CJ.
    Cancer Lett; 2003 Jul 18; 197(1-2):137-43. PubMed ID: 12880973
    [Abstract] [Full Text] [Related]

  • 7. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
    Grotzer MA, Eggert A, Zuzak TJ, Janss AJ, Marwaha S, Wiewrodt BR, Ikegaki N, Brodeur GM, Phillips PC.
    Oncogene; 2000 Sep 21; 19(40):4604-10. PubMed ID: 11030149
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
    Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegaki N, Brodeur GM.
    Cancer Res; 2001 Feb 15; 61(4):1314-9. PubMed ID: 11245427
    [Abstract] [Full Text] [Related]

  • 10. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.
    Fulda S, Debatin KM.
    Oncogene; 2002 Apr 04; 21(15):2295-308. PubMed ID: 11948413
    [Abstract] [Full Text] [Related]

  • 11. Synergistic induction of apoptosis in murine hepatoma Hepa1-6 cells by IFN-gamma and TNF-alpha.
    Sasagawa T, Hlaing M, Akaike T.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):674-80. PubMed ID: 10860813
    [Abstract] [Full Text] [Related]

  • 12. NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines.
    Fiorucci S, Distrutti E, Ajuebor MN, Mencarelli A, Mannucci R, Palazzetti B, Del Soldato P, Morelli A, Wallace JL.
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep 16; 281(3):G654-65. PubMed ID: 11518677
    [Abstract] [Full Text] [Related]

  • 13. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N.
    Cancer Res; 2000 Aug 15; 60(16):4315-9. PubMed ID: 10969767
    [Abstract] [Full Text] [Related]

  • 14. Clustering of hypermethylated genes in neuroblastoma.
    van Noesel MM, van Bezouw S, Voûte PA, Herman JG, Pieters R, Versteeg R.
    Genes Chromosomes Cancer; 2003 Nov 15; 38(3):226-33. PubMed ID: 14506696
    [Abstract] [Full Text] [Related]

  • 15. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death.
    Teitz T, Lahti JM, Kidd VJ.
    J Mol Med (Berl); 2001 Aug 15; 79(8):428-36. PubMed ID: 11511973
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma.
    Geiger K, Hagenbuchner J, Rupp M, Fiegl H, Sergi C, Meister B, Kiechl-Kohlendorfer U, Müller T, Ausserlechner MJ, Obexer P.
    Mol Biol Cell; 2012 Jun 15; 23(11):2226-34. PubMed ID: 22493319
    [Abstract] [Full Text] [Related]

  • 19. 5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.
    Fulda S, Debatin KM.
    Oncogene; 2006 Aug 24; 25(37):5125-33. PubMed ID: 16607283
    [Abstract] [Full Text] [Related]

  • 20. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.
    Mühlethaler-Mottet A, Bourloud KB, Auderset K, Joseph JM, Gross N.
    Oncogene; 2004 Jul 15; 23(32):5415-25. PubMed ID: 15094781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.